tetradecanoylphorbol acetate has been researched along with dabrafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayward, R; Lo, RS; Marais, R; Martin, M; Niculescu-Duvaz, D; Sanchez-Laorden, B; Springer, C; Viros, A; Yashar, S; Yu, CC; Zambon, A | 1 |
| Bae, JS; Kim, J; Kim, SC; Ku, SK | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and dabrafenib
| Article | Year |
|---|---|
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Cell Line; Cell Proliferation; Fluorouracil; Humans; Imidazoles; Indoles; Melanoma; Mice; Oximes; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Tetradecanoylphorbol Acetate; Vemurafenib | 2013 |
Suppressive effects of dabrafenib on endothelial protein C receptor shedding.
Topics: ADAM17 Protein; Animals; Antigens, CD; Cells, Cultured; Down-Regulation; Drug Repositioning; Endothelial Protein C Receptor; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Oximes; Phosphorylation; Protein Kinase Inhibitors; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2017 |